Info

Integrated Plant Genetics, Inc. (IPG) is a development stage biotechnology company, in business to develop, produce and license new genetic technologies for the purpose of horticultural, agricultural and forest tree improvement and disease control. The Company currently provides gene engineering services to industry through research contracts and also disease resistance genes and freedom-to-operate technologies, including plant transformation technologies and methods through our marketing partners. We are currently devoping genetic technologies to make plants resistant to diseases for which there is presently no or little resistance or tolerance. As IPG expands and its technology improves, we anticipate licensing our improved genetic traits ("genetic software") to established plant nurseries and seed producers. IPG's offices, research laboratory and transgenic plant production facilities are located in the Sid Martin Biotechnology Development Institute (BDI) in Alachua, Florida, approximately 18 miles from the University of Florida campus. IPG's core technologies, Disease Block and Twin Block represent a paradigm shift in scientific thinking about methods to control plant diseases. Although traditional breeding methods have relied on plant resistance genes and natural resistance mechanisms, it is a fact that most plant resistance genes have been defeated by evolving pathogen populations. Recent success in the control of virus diseases of plants by genetic engineering does not depend upon or even utilize traditional plant resistance genes. Rather such control was achieved by first understanding the mechanism by which viruses caused disease, and then blocking critical parts of the mechanism. IPG's core technologies, including plant transformation and disease resistance, provide the platforms for future development of specific applications to control plant diseases. Some of these technologies are partly owned by the University of Florida and are exclusively licensed to IPG for sublicensing. Our History: IPG is a Delaware C-Corporation, founded and incorporated by Dr. Dean Gabriel in 1998. The Company became a BDI Licensee in September, 1998. Grants and Awards: IPG has been awarded five federal grants to further develop transgenic plant technologies: two Phase I SBIR grant awards, one from USDA and the other from NSF. In addition, IPG was awarded two grants from USDA's Animal and Plant Health Inspection Service (APHIS) and a Phase II SBIR grant from NSF to develop citrus trees resistant to citrus canker disease. For general inquiries, please send e-mail to info@ipgenetics.com. For web site errors or content issues, please e-mail webmaster@ipgenetics.com.